title: Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure.
abstract: BACKGROUND
  The failing myocardium is characterized by decreased force production, slowed relaxation, and depressed responses to beta-adrenergic stimulation. In some heart failure patients, heart function is so poor that a left ventricular assist device (LVAD) is inserted as a bridge to transplantation. In the present research, we investigated whether circulatory support with an LVAD influenced the functional properties of myocytes from the failing heart.
  
  
  RESULTS
  Myocytes were isolated from human explanted failing hearts (HF-myocytes) and failing hearts with antecedent LVAD support (HF-LVAD-myocytes). Studies of myocyte function indicated that the magnitude of contraction was greater (9.6+/-0.7% versus 6.9+/-0.5% shortening), the time to peak contraction was significantly abbreviated (0.37+/-0.01 versus 0.75+/-0.04 seconds), and the time to 50% relaxation was reduced (0.55+/-0.02 versus 1.45+/-0.11 seconds) in the HF-LVAD-myocytes compared with the HF-myocytes (P<0.05). The HF-LVAD-myocytes had larger contractions than the HF-myocytes at all frequencies of stimulation tested. The negative force-frequency relationship of the HF-myocytes was improved in HF-LVAD-myocytes but was not reversed. Responses to beta-adrenergic stimulation (by isoproterenol) were greater in HF-LVAD-myocytes versus HF-myocytes.
  
  
  CONCLUSIONS
  The results of the study strongly support the idea that circulatory support with an LVAD improves myocyte contractile properties and increases beta-adrenergic responsiveness.
authors.affiliation: Department of Physiology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
authors.forename: K
authors.initials: K
authors.lastname: Dipla
authors.forename: J A
authors.initials: JA
authors.lastname: Mattiello
authors.forename: V
authors.initials: V
authors.lastname: Jeevanandam
authors.forename: S R
authors.initials: SR
authors.lastname: Houser
authors.forename: K B
authors.initials: KB
authors.lastname: Margulies
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D003326:Coronary Circulation; D004558:Electric Stimulation; D004594:Electrophysiology; D005260:Female; D005456:Fluorescent Dyes; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans; D007211:Indoles; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000502:physiology*; D009200:Myocardial Contraction / Q000502:physiology; D009206:Myocardium / Q000166:cytology*; D018487:Ventricular Dysfunction, Left / Q000628:therapy
chemical_list: D000318:Adrenergic beta-Agonists; D005456:Fluorescent Dyes; D007211:Indoles; D007545:Isoproterenol; C048960:indo-1